Loading...

PLRX PLIANT THERAPEUTICS INC Management Changes 8-K Filing

PLNT

PLRX

PLIANT THERAPEUTICS INC

(PLRX)

2025 8-K

Management Change

Financial Results Revealed

Executive Departure

Loan Agreement Termination

Financial Statements

Financial Statements

Management Changes

Stockholder Rights

Q4 Financial Results

Q3 Financial Results

Bylaw Amendment

Earnings Report

Positive Clinical Trial Dat...

Board Appointment and Annua...

Clinical Trial Results

Financial Results Announcement

Loan Agreement and Clinical...

Results of Operations and F...

Clinical Trial Results

Financial Results Announcement

Lease Agreement

Positive Clinical Trial Dat...

Financial Results Announcement

Annual Meeting of Stockholders

Financial Results Announcement

Clinical Trial Results

Results of Operations and F...

Board Expansion and New App...

Termination of Collaboratio...

Clinical Trial Results

External Links:

Pliant Therapeutics, Inc. reported the resignation of Chief Business Officer Hans Hull on October 20, 2025, effective immediately, with no disagreements involved.

AI Assistant

PLIANT THERAPEUTICS INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.